News & Events
NASoP Annual (Virtual) Meeting – 07-08 November 2022
Prof. Moride, President and founder of YOLARX Consultants, presented “Opioids, how are we doing? Impact of opioids-related policies and RMMs on ADRs” at the North American Chapter of the International Society of Pharmacovigilance (NASoP) Annual (Virtual) Meeting on 08 November 2022 (08:00–09:50 AM). If you would like to learn more, contact us: contact@yolarx.com. Read more
DIA Canadian Annual Meeting – 18-19 October 2022 – Ottawa (Canada)
Prof. Moride, President and founder of YOLARX Consultants, presented at DIA Canada, “Key Considerations for Successful Risk Minimization” on 19 October 2022 (09:20–10:35 AM). If you would like to learn more, contact us: contact@yolarx.com.
Article “Impact of the COVID-19 Pandemic on Patterns of Prescription Opioid Use: A Retrospective Cohort Study of Adults Without a Cancer Diagnosis Initiating Opioids Using Administrative Claims Data” released in ‘Drugs – Real World Outcomes’ today
YOLARX Consultants is proud to announce the release of our researchers’ latest contribution to advance the understanding of the impact of the COVID-19 pandemic on the use of prescription opioids in Canada. Read more
21st Annual Meeting of the International Society of Pharmacovigilance (ISoP 2022) – Verona (Italy) – 20-23 September 2022
YOLARX attended ISoP’s 2022 Annual Meeting which took place from 20 to 23 September in Verona, Italy under the theme “A new Era of Pharmacovigilance: challenges and opportunities”. Read more
38th International Conference on Pharmacoepidemiology & Therapeutic Risk Management (ICPE) 2020, Copenhagen – Denmark, 24-28 August 2022
YOLARX participated at ICPE 2022 with 3 posters, 1 oral presentation, and 1 pre-conference course. Read more
Article “Evaluation of interventions and policies on opioids in Canada: A mixed-methods descriptive study” released in ‘International Journal of Environmental Research and Public Health’ today
YOLARX Consultants is proud to announce the release of our researchers’ latest contribution to advance the understanding of “all components of the therapeutic risk minimization framework (i.e., intervention coverage, process indicators, health outcomes)” for opioids in Canada. Read more
DUPHAT – Dubai International Pharmaceuticals & Technologies Conference and Exhibition – 22-24 February 2022
Prof. Moride, president and founder of YOLARX Consultants, attended the 2022 DUPHAT, the biggest pharmaceutical event in the Middle East & Africa. She presented on the “Impact of the COVID-19 pandemic on risk management and risk minimization” as well as “New insights in therapeutic risk management, a focus on pharmacists’ role”.
20th Annual Meeting of the International Society of Pharmacovigilance (ISoP 2021) – Muscat (Oman) – 08-10 November 2021
Prof. Moride, president and founder of YolaRx Consultants, will speak about “Risk management and minimization” presented in the session on “Integrating safety data and knowledge from different information sources” which will take place on Monday, November 8th, 17:00 – 18:30, UTC.
We are hiring: Research Associate in Pharmacoepidemiology
You would like to integrate into a company that is constantly evolving, to join a young and dynamic team and to take on new challenges? Consult our job openings and submit your application to: contact@yolarx.com. Read more
36th International Conference on Pharmacoepidemiology & Therapeutic Risk Management (ICPE) 2020 – All Access, 16-17 September 2020
YOLARX attended the virtual conference “ICPE 2020 – All Access” with several posters and one oral presentation. If you’d like to hear more, please contact us at: contact@yolarx.com. Read more